Liminatus Pharma, Inc. (LIMN)
0.953
-0.03
(-2.76%)
USD |
NASDAQ |
Dec 04, 16:00
1.00
+0.05
(+4.93%)
After-Hours: 05:36
Liminatus Pharma Total Liabilities (Quarterly): 2.988M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CDT Equity, Inc. | 4.274M |
| LENZ Therapeutics, Inc. | 16.78M |
| Oruka Therapeutics, Inc. | 22.46M |
| Maze Therapeutics, Inc. | 42.62M |
| MapLight Therapeutics, Inc. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.342M |
| Shareholders Equity (Quarterly) | -1.646M |
| Debt to Equity Ratio | -0.8765 |
| Current Ratio | 0.4201 |
| Net Debt Paydown Yield | 1.03% |